ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...

Currently, Hexiris is developing several groundbreaking devices. One example is our Advanced Technology Device designed for office-based Minimally Invasive Glaucoma Surgeries (MIGS). This first-of-its ...

The MarketWatch News Department was not involved in the creation of this content. -- New company to develop novel surgical device for mild-to-severe glaucoma, improving safety, efficiency, and ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...